Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Capricor Therapeutics (OTCBB: CAPR) (a subsidiary of Nile Therapeutics; aka Capricor)
Capricor Therapeutics (OTCBB: CAPR) (a subsidiary of Nile Therapeutics; aka Capricor)
Reports Graph
1-Allogeneic cardiac-derived cells (CDCs) aimed at attenuating and potentially improving heart damage resulting from heart failure (HF) and 2-Dual natriuretic peptide receptor agonist to prevent patients from an acute episode of HF following hospital discharge
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
CEO presentation
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next